A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Telmisartan, Amlodipine and Indapamide (WIDAPLIK)

Telmisartan, Amlodipine and Indapamide lowers blood pressure by blocking angiotensin II receptors, used for hypertension and kidney protection.

First FDA approval2025-10-20
Generic availableNo (brand-only)
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one
Lowest NADAC
/unit
0 NDCs benchmarked, lowest of all strengths.
Average NADAC
Across all dosage forms in distribution.
Highest NADAC
Range is tight.
Plans with PA
0 / 329
Zero PA friction — switching is purely formulary.

Questions a plan sponsor actually asks.

FAQPage schema9 entries indexed · 4 visible
What is Telmisartan, Amlodipine and Indapamide used for?

Telmisartan, Amlodipine and Indapamide lowers blood pressure by blocking angiotensin II receptors, used for hypertension and kidney protection.

Is there a generic for Telmisartan, Amlodipine and Indapamide?

No. Telmisartan, Amlodipine and Indapamide is brand-only with no generic equivalents currently in market.

How much does my plan pay for Telmisartan, Amlodipine and Indapamide?

NADAC pricing data not currently available for this drug.

Is Telmisartan, Amlodipine and Indapamide on the FDA shortage list?

No. Telmisartan, Amlodipine and Indapamide is not currently on the FDA Drug Shortage Database.

5 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

Angiotensin 2 Receptor Blocker6 alternatives in D1
01
Amlodipine and Valsartan
Brand: Exforge
$0.439Lowest NADAC
8Generic mfrs
CY24 Part D spend
Compare →
02
Candesartan Cilexetil
Brand: ATACAND
$0.495Lowest NADAC
5Generic mfrs
$61.4MCY24 Part D spend
Compare →
03
Irbesartan
Brand: Avapro
$0.084Lowest NADAC
15Generic mfrs
$84.3MCY24 Part D spend
Compare →
04
Irbesartan and Hydrochlorothiazide
Brand: Avalide
$0.153Lowest NADAC
9Generic mfrs
CY24 Part D spend
Compare →
05
Olmesartan Medoxomil
Brand: Benicar
$0.058Lowest NADAC
19Generic mfrs
$127.5MCY24 Part D spend
Compare →
06
Sacubitril and Valsartan
Brand: ENTRESTO
$0.596Lowest NADAC
14Generic mfrs
CY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.